GlassScriptPhysician profile
Hunter Lee Fuentes
NPI 1497118681
$16,511.07
in general payments reported to CMS, 2019-2025
43 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $182 · 2022: $9,586 · 2023: $5,335 · 2024: $1,080 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,512 · Travel and Lodging: $1,998 · Education: $210 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,511.90 |
| Travel and Lodging | $1,997.77 |
| Education | $210.17 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $8,560.39 | 2021-2024 | |
| Intuitive Surgical, INC. | $2,579.59 | 2022-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Angiodynamics, INC. | $1,982.75 | 2022-2024 | Nanoknife |
| Janssen Biotech, INC. | $527.13 | 2021-2025 | Erleada, Akeega, Balversa |
| Abbvie INC. | $369.25 | 2022-2025 | |
| Astellas Pharma US INC | $332.23 | 2021-2024 | Xtandi |
| Pfizer INC. | $243.15 | 2021-2024 | |
| Dendreon Pharmaceuticals LLC | $172.38 | 2022-2024 | Provenge |
| Boston Scientific Corporation | $164.10 | 2023-2025 | Spaceoar Vue System - 10ml, Axonics, Rezum Generator |
| Myriad Genetic Laboratories, INC. | $147.56 | 2023 | Prolaris, Myrisk |
| Procept Biorobotics Corporation | $143.57 | 2022-2023 | Aquabeam Robotic System |
| Sun Pharmaceutical Industries INC. | $104.81 | 2024 | |
| Sumitomo Pharma America, INC. | $97.65 | 2023 | Orgovyx |
| Merck Sharp & Dohme LLC | $63.27 | 2023-2024 | Welireg, Keytruda, Lynparza |
| Endo Pharmaceuticals INC. | $62.14 | 2022-2023 | Aveed, Edex, Xiaflex |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $60.41 | 2023 | Interstim |
| Antares Pharma, INC. | $59.35 | 2022-2024 | Xyosted, Nocdurna, Tlando |
| C. R. Bard, INC. & Subsidiaries | $57.33 | 2021-2023 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $56.27 | 2021-2022 | |
| Ambu INC. | $50.57 | 2023 | |
| Telix Pharmaceuticals | $49.44 | 2022 | |
| Laborie Medical Technologies Corp. | $48.41 | 2022-2024 | Optilume Bph Drug Coated Balloon Catheter |
| 180 Medical, INC. | $44.24 | 2021-2024 | |
| Hollister Incorporated | $44.07 | 2022 | |
| Dentsply Ih Ab | $37.22 | 2024 | Lofric |
| Blue Earth Diagnostics | $36.47 | 2021-2023 | |
| Rochester Medical Corporation | $34.00 | 2022 | |
| Convatec INC. | $34.00 | 2023 | |
| Progenics Pharmaceuticals, INC. | $32.91 | 2023-2024 | Pylarify |
| Palette Life Sciences, INC. | $31.76 | 2022 | |
| Ferring Pharmaceuticals INC. | $30.13 | 2024 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $29.89 | 2024 | |
| Urogen Pharma, INC. | $26.05 | 2023 | Jelmyto |
| Immunitybio, INC. | $25.28 | 2024 | |
| Tolmar, INC. | $23.85 | 2023 | |
| Halozyme INC | $23.66 | 2023 | |
| Endo USA, INC. | $21.07 | 2025 | Xiaflex, Aveed |
| Coloplast Corp | $19.24 | 2021 | |
| Urovant Sciences INC | $18.98 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.74 | 2023 | Lynparza |
| Kowa Pharmaceuticals America, INC. | $17.33 | 2023 | Seglentis |
| Allergan, INC. | $15.44 | 2022 | |
| Abc Home Medical Supply, INC. | $14.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Fuentes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.